The effect of metyrapone on aldosterone secretion in man.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000324:Adrenocorticotropic Hormone / Q000502:physiology; D000328:Adult; D000450:Aldosterone / Q000378:metabolism*; D001835:Body Weight; D002986:Clinical Trials as Topic; D003480:Cushing Syndrome / Q000503:physiopathology*; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000503:physiopathology*; D007018:Hypopituitarism / Q000503:physiopathology*; D008297:Male; D008797:Metyrapone / Q000494:pharmacology*; D008875:Middle Aged; D009318:Natriuresis; D010913:Pituitary-Adrenal System / Q000187:drug effects; D011188:Potassium / Q000652:urine; D012636:Secretory Rate
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000450:Aldosterone; D000324:Adrenocorticotropic Hormone; D011188:Potassium; D008797:Metyrapone